Aeterna Zentaris (AEZS) Says MAA for Macrilen for Evaluation of Adult Growth Hormone Deficiency Accepted by EMA
Tweet Send to a Friend
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) announced that the Marketing Authorization Application (“MAA”) for the use of Macrilen™ (macimorelin) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
